More than 6 million genetic markers were analyzed across 12,339 BPD patients and over 1 million controls, yielding six associated genomic regions before a replication dataset added five more variants.
Nine functional genes sit within or near the 11 regions, and the detected variants explain about 17% of BPD's genetic contribution—below the 46% to 69% heritability estimated in twin studies.
The study also found overlap between BPD-linked variants and those tied to depression, antisocial behavior and ADHD, with the strongest shared genetic vulnerability seen in PTSD.
All participants were of European ancestry, and researchers said the five replication-stage variants still need follow-up validation as work shifts to clarifying the underlying biology.
With BPD now linked to specific genes, is the role of childhood trauma in its development being overstated?
If genes for BPD, PTSD, and depression overlap, are they truly separate disorders or different facets of one condition?
Landmark GWAS of Over 1 Million Participants Reveals Genetic Architecture and Clinical Implications of Borderline Personality Disorder
Overview
A landmark genome-wide association study (GWAS) published in July 2026 marked a major advance in understanding Borderline Personality Disorder (BPD). Researchers examined over six million genetic markers by integrating individual-level data from 17 studies and summary statistics from 10 large biobanks, covering more than 12,000 BPD cases and over a million controls of European ancestry. By combining these datasets into larger groups for analysis, the study gathered robust genetic evidence and laid a strong foundation for understanding the complex genetic basis of BPD.